125 related articles for article (PubMed ID: 34044389)
1. Prognostic Value of Microvessel Density in Non-Hodgkin Lymphoma: A Meta-Analysis.
Wu J; Ma S; Sun L; Qin Z; Wang Z; Wang N; Lin M
Acta Haematol; 2021; 144(6):603-612. PubMed ID: 34044389
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of tumour-associated macrophages in Non-Hodgkin's lymphoma: A systematic review and meta-analysis.
Xu X; Li Z; Liu J; Zhu F; Wang Z; Wang J; Zhang J; Wang H; Zhai Z
Scand J Immunol; 2020 Jan; 91(1):e12814. PubMed ID: 31419843
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Microvessel Density in Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.
Dong Y; Ma G; Liu Y; Lu S; Liu L
Dis Markers; 2020; 2020():8842795. PubMed ID: 33062071
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of tumor-associated macrophages detected by immunostaining in diffuse large B cell lymphoma: A meta-analysis.
Lin M; Ma S; Sun L; Qin Z
Front Oncol; 2022; 12():1094400. PubMed ID: 36741724
[TBL] [Abstract][Full Text] [Related]
5. Microvessel density as a prognostic factor in ovarian cancer: a systematic review and meta-analysis.
He L; Wang Q; Zhao X
Asian Pac J Cancer Prev; 2015; 16(3):869-74. PubMed ID: 25735375
[TBL] [Abstract][Full Text] [Related]
6. Effects of microvascular density on primary pulmonary non-Hodgkin's lymphoma (PPL).
Yang M; Zhao S; Zhang X; Wang X; Zhang M; Wang Y; Zhang Q
Tumour Biol; 2012 Dec; 33(6):2143-50. PubMed ID: 22875783
[TBL] [Abstract][Full Text] [Related]
7. Diabetes and the Prognosis in Patients With Non-Hodgkin Lymphoma: A Meta-analysis of Cohort Studies.
Han Z; Xu H; Zhao M; Jing F; Xue H; Xiao S
Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):e77-e88. PubMed ID: 34593361
[TBL] [Abstract][Full Text] [Related]
8. Distinct clinical features and prognostic factors of hepatitis C virus-associated non-Hodgkin's lymphoma: a systematic review and meta-analysis.
Zhang M; Gao F; Peng L; Shen L; Zhao P; Ni B; Hou J; Huang H
Cancer Cell Int; 2021 Oct; 21(1):524. PubMed ID: 34627251
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of latent membrane protein 1 expression in non-Hodgkin lymphoma: A meta-analysis.
Li XM; Xiao WH; Zhao HX
Medicine (Baltimore); 2017 Apr; 96(14):e6512. PubMed ID: 28383415
[TBL] [Abstract][Full Text] [Related]
10. Different predictive values of microvessel density for biochemical recurrence among different PCa populations: A systematic review and meta-analysis.
Jiang J; Li J; Xiong X; Zhang S; Tan D; Yang L; Wei Q
Cancer Med; 2023 Feb; 12(3):2166-2178. PubMed ID: 35933720
[TBL] [Abstract][Full Text] [Related]
11. Microvessel Density as a Surrogate Prognostic Marker in Patients with Multiple Myeloma: A Meta-Analysis.
Ntellas P; Perivoliotis K; Dadouli K; Koukoulis GK; Ioannou M
Acta Haematol; 2017; 138(2):77-84. PubMed ID: 28796988
[TBL] [Abstract][Full Text] [Related]
12. Role of gelatinases (MMP-2 and MMP-9), TIMP-1, vascular endothelial growth factor (VEGF), and microvessel density on the clinicopathological behavior of childhood non-Hodgkin lymphoma.
Citak EC; Oguz A; Karadeniz C; Akyurek N
Pediatr Hematol Oncol; 2008; 25(1):55-66. PubMed ID: 18231955
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of EBV latent membrane protein 1 expression in lymphomas: evidence from 15 studies.
Mao Y; Lu MP; Lin H; Zhang DW; Liu Y; Li QD; Lv ZG; Xu JR; Chen RJ; Zhu J
PLoS One; 2013; 8(4):e60313. PubMed ID: 23613723
[TBL] [Abstract][Full Text] [Related]
14. Clinical prognostic analysis of 116 patients with primary intestinal non-Hodgkin lymphoma.
Gou HF; Zang J; Jiang M; Yang Y; Cao D; Chen XC
Med Oncol; 2012 Mar; 29(1):227-34. PubMed ID: 21193968
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of serum beta-2 microglobulin in patients with non-Hodgkin lymphoma.
Wu L; Wang T; Gui W; Lin H; Xie K; Wang H; Gao T; Zhang X; Liu L; Han T; Tian Y; Hou L
Oncology; 2014; 87(1):40-7. PubMed ID: 24969158
[TBL] [Abstract][Full Text] [Related]
16. Innovative analysis of predictors for overall survival from systemic non-Hodgkin T cell lymphoma using quantile regression analysis.
Huang DY; Hu YF; Wei N; Fu L; Wu L; Shen J; Wang JS; Wang Z
Chin Med J (Engl); 2019 Feb; 132(3):294-301. PubMed ID: 30681495
[TBL] [Abstract][Full Text] [Related]
17. The Role of Lymphocyte to Monocyte Ratio, Microvessel Density and HiGH CD44 Tumor Cell Expression in Non Hodgkin Lymphomas.
Jelicic J; Balint MT; Jovanovic MP; Boricic N; Micev M; Stojsic J; Antic D; Andjelic B; Bila J; Balint B; Pavlovic S; Mihaljevic B
Pathol Oncol Res; 2016 Jul; 22(3):567-77. PubMed ID: 26750138
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Survival Between Autologous and Allogeneic Stem Cell Transplantation in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma: A Meta-Analysis.
Wang J; Duan X; Yang L; Liu X; Hao C; Dong H; Gu H; Tang H; Dong B; Zhang T; Gao G; Liang R
Cell Transplant; 2020; 29():963689720975397. PubMed ID: 33238731
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: A meta-analysis.
Guo B; Tan X; Ke Q; Cen H
PLoS One; 2019; 14(1):e0210224. PubMed ID: 30625203
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis measured by expression of CD34 antigen in lymph nodes of patients with non-Hodgkin's lymphoma.
Mazur G; Wróbel T; Dziegiel P; Jeleń M; Kuliczkowski K; Zabel M
Folia Histochem Cytobiol; 2004; 42(4):241-3. PubMed ID: 15704651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
